Q--Prolastin-C

The contract titled "Q--Prolastin-C" with solicitation number VA25613I0793 was posted on April 25, 2013. It involves the procurement related to the NAICS code 424210, which typically pertains to pharmaceutical or medicinal product wholesale distribution. Although specific details such as the agency name, type of set aside, and office or performance location are not provided, the contract appears to be associated with Grifols Therapeutics, Inc., as indicated by the file name. The absence of additional information on points of contact and organization type suggests a focus primarily on the acquisition of a therapeutic product rather than broader service or administrative components. This contract likely concerns the supply or distribution of Prolastin-C, a plasma-derived therapy used to treat Alpha-1 Antitrypsin Deficiency. Given the nature of the product and the contracting industry standards, the agreement would generally cover terms related to delivery schedules, quality assurance, handling and storage requirements, and pricing arrangements to ensure the specialized biological product meets the needs of the end users, potentially within a healthcare or veterans’ administration setting. Despite limited details, this contract reflects the procurement process for a critical therapeutic agent, emphasizing compliance with federal acquisition requirements and quality standards necessary for medical products.